IRIS Accounts Production v25.1.0.734 15472664 director 7.2.24 28.2.25 28.2.25 false true false false true false Ordinary 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh154726642024-02-06154726642025-02-28154726642024-02-072025-02-28154726642024-02-0615472664ns15:EnglandWales2024-02-072025-02-2815472664ns14:PoundSterling2024-02-072025-02-2815472664ns10:Director12024-02-072025-02-2815472664ns10:PrivateLimitedCompanyLtd2024-02-072025-02-2815472664ns10:SmallEntities2024-02-072025-02-2815472664ns10:AuditExempt-NoAccountantsReport2024-02-072025-02-2815472664ns10:SmallCompaniesRegimeForDirectorsReport2024-02-072025-02-2815472664ns10:SmallCompaniesRegimeForAccounts2024-02-072025-02-2815472664ns10:FullAccounts2024-02-072025-02-2815472664ns10:OrdinaryShareClass12024-02-072025-02-28154726641ns10:OrdinaryShareClass12024-02-072025-02-2815472664ns10:RegisteredOffice2024-02-072025-02-2815472664ns5:CurrentFinancialInstruments2025-02-2815472664ns5:ShareCapital2025-02-2815472664ns5:RetainedEarningsAccumulatedLosses2025-02-2815472664ns10:OrdinaryShareClass12025-02-28
REGISTERED NUMBER: 15472664 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 7 FEBRUARY 2024 TO 28 FEBRUARY 2025

FOR

WISE BLOODSTOCK LTD

WISE BLOODSTOCK LTD (REGISTERED NUMBER: 15472664)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 7 FEBRUARY 2024 TO 28 FEBRUARY 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


WISE BLOODSTOCK LTD

COMPANY INFORMATION
FOR THE PERIOD 7 FEBRUARY 2024 TO 28 FEBRUARY 2025







DIRECTOR: D J Wise





REGISTERED OFFICE: 2 Woodway Cottages
Woodway Road, Didcot
Oxford
Oxfordshire
OX11 9EY





REGISTERED NUMBER: 15472664 (England and Wales)





ACCOUNTANTS: Fawcetts LLP
Chartered Accountants
Windover House
St. Ann Street
Salisbury
SP1 2DR

WISE BLOODSTOCK LTD (REGISTERED NUMBER: 15472664)

BALANCE SHEET
28 FEBRUARY 2025

Notes £   
CURRENT ASSETS
Stocks 4 5,040
Debtors 5 840
Cash at bank 20,897
26,777
CREDITORS
Amounts falling due within one year 6 28,666
NET CURRENT LIABILITIES (1,889 )
TOTAL ASSETS LESS CURRENT LIABILITIES (1,889 )

CAPITAL AND RESERVES
Called up share capital 7 1
Retained earnings (1,890 )
SHAREHOLDERS' FUNDS (1,889 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 28 February 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 28 February 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 26 April 2025 and were signed by:





D J Wise - Director


WISE BLOODSTOCK LTD (REGISTERED NUMBER: 15472664)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 7 FEBRUARY 2024 TO 28 FEBRUARY 2025


1. STATUTORY INFORMATION

Wise Bloodstock Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements have been prepared on a going concern basis and are presented in Sterling (£) which is the functional currency of the company.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

The company is reliant on the support of the director to enable Wise Bloodstock Limited to meet its day-to-day financial obligations. The director has confirmed that he will continue to support the company for at least twelve months beyond the approval date of these financial statements, and will not withdraw the loan facility provided if this would render the company unable to pay its liabilities as they fall due. On this basis, the director believes that is is prudent to prepare the accounts on a going concern basis.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

WISE BLOODSTOCK LTD (REGISTERED NUMBER: 15472664)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 7 FEBRUARY 2024 TO 28 FEBRUARY 2025


2. ACCOUNTING POLICIES - continued

Debtors
Debtors are measured at their recoverable amount.

Creditors and provisions
Creditors and provisions are recognised where the company has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 .

4. STOCKS
£   
Bloodstock valuation 5,040

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Other debtors 840

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Directors' current accounts 27,526
Accrued expenses 1,140
28,666

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
1 Ordinary £1 1

1 Ordinary share of £1 was allotted and fully paid for cash at par during the period.

8. RELATED PARTY DISCLOSURES

Mr D Wise
Sole director and shareholder

At the balance sheet date, the amount owed by the company to Mr D Wise, the sole director and shareholder, was £27,526. This balance has been included in Other Creditors and is given interest free.